QuantumBio has had a busy year, and its collaborators and staff will be presenting four talks at the Meeting covering NMRScoreing, QMScore, PWD, Protein/Protein Interaction characterization, and current perspectives. See the following links for more details, updated scheduling, and location details:
- 339 – Quantum mechanical pair-wise decomposition analysis of protein kinase B inhibitors: Validating a new tool for fragment-based drug design
Presented on Wednesday, August 25th by Dr. Alan C. Gibbs – Johnson & Johnson Pharmaceutical, Spring House, PA, United States. The paper for this presentation is available here.
- 340 – Fragment based drug design using differential chemical shift perturbation induced upon binding Presented on Wednesday, August 25th by Dr. Lance M. Westerhoff – Quantumbio Inc, State college, PA, United States.
- 368 – How to build a better mousetrap: Experiences with docking/scoring benchmarks – including the GlaxoSmithKline set – and what has been learned Presented on Wednesday, August 25th by Dr. Lance M. Westerhoff – Quantumbio Inc, State college, PA, United States.
- 411 – Computational alanine scanning with linear scaling semi-empirical quantum mechanical methods Presented on Wednesday, August 26th by Dr. David J. Diller – Consultant, East Windsor, NJ, United States. The paper related to this presentation is available here.